Sponsor Pipeline

Boryung Pharmaceutical Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
23
Active Trials
15
Recruiting
10
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 2
3
Phase 1
8
Not specified
11
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06972732 A Phase IV Clinical Trial to Compare the Efficacy and Safety of Metformin+Sodium-Glucose… Type 2 Diabetes Recruiting
Phase 2
NCT06821945 A Clinical Trial to Evaluate the Safety and Efficacy of Olanzapine Titration Schedule in… Schizophrenia Recruiting
NCT07180771 A Study of Bosmolisib (BR101801) in Participants With R/R PTCL. Peripheral T Cell Lymphoma Not Yet Recruiting
NCT07373613 A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With… Essential Hypertension Not Yet Recruiting
Phase 1
NCT06867497 A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety… Metastatic Adenocarcinoma of the Pancreas Recruiting
NCT07069335 A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in… Ovarian Cancer Recruiting
NCT07083388 A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and… Diabetes Mellitus Recruiting
NCT07083401 A Study to Evaluate the Pharmacokinetics and Safety Between "BR3006" and… Diabete Mellitus Recruiting
NCT07421375 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421388 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421401 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
NCT07421414 A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015-A… Essential Hypertension Not Yet Recruiting
Not specified
NCT06649162 A Study to Identify the Risk of Non-alcoholic Fatty Liver Disease (NAFLD) in Patients… Type 2 Diabetes Recruiting
NCT06126016 A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj. Chronic Kidney Disease 5D Recruiting
NCT05413057 An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or… Hypertension,Essential Recruiting
NCT06314919 A Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of… Primary Hypercholesterolemia Recruiting
NCT06537752 A Study to Evaluate Ethanol-induced Symptoms and Safety in Breast Cancer Patients Breast Cancer Recruiting
NCT05970237 A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2… Diabetes Mellitus Recruiting
NCT06021483 Observational Study to Evaluate the Safety and Efficacy of Zepzelca™ Injection SCLC Recruiting
NCT07263178 A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic… Metastatic Colorectal Cancer Recruiting
NCT07263191 A Study of Olanzapine in Participants With Bipolar Disorder. Bipolar Disorder Recruiting
NCT04416490 Oxaliplatin Adjuvant Chemotherapy After Curative Resection of Primary Colon Cancer Stage II Colon Cancer Active, Not Recruiting
NCT07685054 To Evaluate the Renal Protective Effects and Safety of 'Fimasartan and Atorvastatin' or… Essential Hypertension Not Yet Recruiting
Disease Areas
Get alerts when Boryung Pharmaceutical Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free